 cell cycl bladder carcinoma monoclon antibodi current method prognosi transit cell carcinoma bladder fail reliabl inform futur tumour behaviour monoclon antibodi antigen present cell reactiv convent prognost indic sever tumour studi antibodi proport cell activ divis transit cell carcinoma bladder proport cell muscl invas tumour superfici tumour tumour proport cell differenti tumour result reactiv high tumour stage poor differenti easi method tumour cell turnov addit prognost inform